Company Lookup
عربي
 
 

Market News

This Month News

This Month News

send to a friend by email

BPC posts net income of $1.79 million in Q1 2023

2023-05-16

According to the financial statements of Birzeit Pharmaceuticals for the 1st Quarter of 2023, Net profit after tax of the period reached 1,794,391 USD Compared with Net profit after tax 3,074,920 USD for 2022, a net decrease in profit of 41.64%.Total assets of the company reached 126,676,896 USD compared with total assets of 123,003,262 USD at the end of year 2022, a net increase of 2.99%.Total liabilities of the company reached 20,029,282 USD compared with total liabilities of 19,489,454 USD at the end of year 2022, a net increase of 2.76%. Net ownership equity of the company reached 106,647,614 USD (Including Non-Controlling Interests of 942,938 USD) compared with total owner equity of 103,513,808 USD (Including Non-Controlling Interests of 923,623 USD) at the end of year 2022, a net increase of 3.03%.

 


 

2024-04-15
TPIC proposes distributing 5% stocks dividends for the year 2023

2024-04-14
PIBC recommends distributing 2.5641% stocks dividends for the year 2023

2024-04-14
ABRAJ recommends converting the company from public shareholding to private shareholding

2024-04-14
NCI recommends distributing 12% cash dividends for the year 2023

2024-04-04
TRUST approves distributing 10% cash dividends for the year 2023

2024-04-04
Al-Quds Index stands-still with the start of April

2024-04-03
TIC approves distributing 15% cash dividends for the year 2023

2024-04-01
NSC recommends distributing 7% stocks dividends for the year 2023

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013
PHP Notice: Undefined index: archive in C:\Inetpub\wwwroot\sahem\menu.php on line 403